Sintilimab, CAS [[2072873-06-2]]

Produktübersicht

• Artikelname: Sintilimab, CAS [[2072873-06-2]]
• Artikelnummer: TGM-T35394
• Hersteller Artikelnummer: T35394
• Alternativnummer: TGM-T35394-1MG,TGM-T35394-5MG,TGM-T35394-10MG,TGM-T35394-25MG,TGM-T35394-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: IBI308 , Sintilimab (anti-PD-1)

Produktbeschreibung

Sintilimab (IBI308) is a humanized IgG4 monoclonal antibody with significant anti-tumor activity that restores endogenous anti-tumor T-cell responses by binding to PD-1 and thereby blocking the interaction of PD-1 with its ligands (PD-L1 and PL-L2).Sintilimab is used in combination with other compounds for the treatment of classical Hodgkins lymphoma, non-cellular lung cancer and esophageal cancer. Sintilimab is used in combination with other compounds to treat classical Hodgkins lymphoma, non-small cell lung cancer and esophageal cancer.

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [2072873-06-2]
• Target-Kategorie: PD-1/PD-L1